The "Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.Report includes an overview of trial numbers and their average ...
Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...